722 filings
Page 2 of 37
8-K
l69ux03ltpzg4ydi2hxv
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
aph694fj9q vlpi9w
4 May 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
jcvq luklj5
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
DEFA14A
33wqp83
23 Mar 23
Additional proxy soliciting materials
7:34am
8-K
ocy5ti8eh7x
13 Mar 23
Entry into a Material Definitive Agreement
4:45pm
8-K
dqagx91jpgxeb1e8et
14 Feb 23
Departure of Directors or Certain Officers
4:35pm
8-K
d8srqbqinnna0
9 Feb 23
Baxter Reports Fourth-quarter and Full-year 2022 Results
7:18am
8-K
289kvfb oe
6 Jan 23
Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders
7:03am
8-K
p1o6o6 ef
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am
8-K
yb3fd1ldipc964lvora
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
8-K
c06ihg0
28 Jul 22
Baxter Reports Second-quarter 2022 Results
7:19am
SD
voa1 du7hbpyx
31 May 22
Conflict minerals disclosure
4:31pm
8-K
vhnizt
25 May 22
Baxter Highlights Business Strategies and Innovation
9:11am
424B3
wmlc53ag
12 May 22
Prospectus supplement
8:58am
EFFECT
6jwhmz8junp
12 May 22
Notice of effectiveness
12:15am